- Home
- KROS vs CCSI Comparison
KROS vs CCSI Comparison
Compare KROS & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | CCSI |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 561.4M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | KROS | CCSI |
|---|---|---|
| Price | $11.49 | $26.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $21.86 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 335.5K | 92.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.00 | N/A |
| EPS | 2.30 | ★ 4.35 |
| Revenue | $243,864,000.00 | ★ $349,696,000.00 |
| Revenue This Year | N/A | $3.33 |
| Revenue Next Year | $2,751.79 | $2.70 |
| P/E Ratio | ★ $5.02 | $5.94 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.42 | $19.24 |
| 52 Week High | $22.55 | $31.67 |
Technical Indicators
Market Signals| Indicator | KROS | CCSI |
|---|---|---|
| Relative Strength Index (RSI) | 44.36 | 51.68 |
| Support Level | $10.56 | $26.42 |
| Resistance Level | $12.65 | $26.62 |
| Average True Range (ATR) | 0.42 | 1.14 |
| MACD | 0.08 | 0.29 |
| Stochastic Oscillator | 37.50 | 55.05 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.